IL104087A - Spheronization compositions containing microcrystalline cellulose and hydrocolloid process for their preparation and solid dosage form thereof - Google Patents

Spheronization compositions containing microcrystalline cellulose and hydrocolloid process for their preparation and solid dosage form thereof

Info

Publication number
IL104087A
IL104087A IL10408792A IL10408792A IL104087A IL 104087 A IL104087 A IL 104087A IL 10408792 A IL10408792 A IL 10408792A IL 10408792 A IL10408792 A IL 10408792A IL 104087 A IL104087 A IL 104087A
Authority
IL
Israel
Prior art keywords
composition
hydrocolloid
cellulose
drug
dosage form
Prior art date
Application number
IL10408792A
Other languages
English (en)
Other versions
IL104087A0 (en
Inventor
David Frank Erkoboni
Scott Allan Fiore
Thomas Albert Wheatley
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of IL104087A0 publication Critical patent/IL104087A0/xx
Publication of IL104087A publication Critical patent/IL104087A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/005—Processes for mixing polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10408792A 1991-12-30 1992-12-14 Spheronization compositions containing microcrystalline cellulose and hydrocolloid process for their preparation and solid dosage form thereof IL104087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81602791A 1991-12-30 1991-12-30

Publications (2)

Publication Number Publication Date
IL104087A0 IL104087A0 (en) 1993-05-13
IL104087A true IL104087A (en) 1998-10-30

Family

ID=25219497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10408792A IL104087A (en) 1991-12-30 1992-12-14 Spheronization compositions containing microcrystalline cellulose and hydrocolloid process for their preparation and solid dosage form thereof

Country Status (16)

Country Link
US (1) US5725886A (de)
EP (1) EP0619731B1 (de)
JP (1) JP2628230B2 (de)
CN (1) CN1074228A (de)
AT (1) ATE196733T1 (de)
AU (1) AU663146B2 (de)
BR (1) BR9206996A (de)
CA (1) CA2126441C (de)
DE (1) DE69231499T2 (de)
ES (1) ES2150438T3 (de)
FI (1) FI943121L (de)
IL (1) IL104087A (de)
MX (1) MX9207438A (de)
NO (1) NO942457D0 (de)
WO (1) WO1993012768A1 (de)
ZA (1) ZA929161B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
TR199900296T2 (xx) * 1996-08-14 1999-06-21 Yamanouchi Europe B.V. Suda ��z�n�r bir bile�ik ve sel�loz i�eren gran�ler �r�nler
CN1086189C (zh) * 1997-06-12 2002-06-12 食品机械和化工公司 超细微晶纤维素组合物及其制备方法
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
EP1233755B1 (de) 1999-09-29 2007-06-27 R.P. Scherer Technologies, Inc. Granulate von arzneistoffsalzen mit hydrolisierter cellulose
US6858725B1 (en) 1999-11-12 2005-02-22 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
BR0109602A (pt) 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
CA2445290A1 (en) * 2001-04-26 2002-11-07 Chenkou Wei A pharmaceutical tablet having a high api content
US7462232B2 (en) 2002-05-14 2008-12-09 Fmc Corporation Microcrystalline cellulose compositions
EP1848292B1 (de) * 2005-02-04 2015-10-14 Philip Morris Products S.A. Zigarette und filter mit cellulosischem geschmackszusatz
US20070000505A1 (en) * 2005-02-24 2007-01-04 Philip Morris Usa Inc. Smoking article with tobacco beads
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
ZA200807571B (en) * 2006-03-01 2009-08-26 Ethypharm Sa Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
CA2657202A1 (en) * 2006-07-28 2008-01-31 Farmaprojects, S.A. Extended release pharmaceutical formulation of metoprolol and process for its preparation
US7998505B2 (en) * 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
ATE476176T1 (de) * 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
SG185257A1 (en) * 2007-10-10 2012-11-29 Avantor Performance Mat Inc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
BRPI0921507A2 (pt) * 2008-11-19 2016-01-19 Avantor Performance Mat Inc composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo
US9221963B2 (en) 2008-11-27 2015-12-29 Speciality Fibres And Materials Ltd. Absorbent material
US9144625B2 (en) 2008-11-27 2015-09-29 Speciality Fibres And Materials Ltd. Cellulose ethylsulfonate-based absorbent material
US8377215B2 (en) 2008-12-18 2013-02-19 Philip Morris Usa Inc. Moist botanical pouch processing
US8863755B2 (en) * 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
US10051884B2 (en) 2010-03-26 2018-08-21 Philip Morris Usa Inc. Controlled release mentholated tobacco beads
US20110277781A1 (en) 2010-03-26 2011-11-17 Philip Morris Usa Inc. Methods for improving quality of mainstream smoke and multicomponent filters and smoking articles therefor
EP2764045B1 (de) 2011-10-05 2017-03-01 FMC Corporation Stabilisatorzusammensetzung aus koattritierter mikrokristalliner cellulose und carboxymethylcellulose, verfahren zu ihrer herstellung und anwendungen davon
US9826763B2 (en) 2011-10-05 2017-11-28 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
WO2013085809A1 (en) 2011-12-09 2013-06-13 Fmc Corporation Co-attrited stabilizer composition having superior gel strength
CN105085992B (zh) * 2015-09-16 2017-12-29 珠海市东辰医药科技有限公司 一种改性微晶纤维素的制备工艺
CN105193738B (zh) * 2015-09-21 2018-09-04 珠海市东辰制药有限公司 一种微晶纤维素丸芯的制备工艺
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1010477A (en) * 1962-05-15 1965-11-17 Fmc Corp Method of making cellulose crystallite aggregates in particulate form and product of such method
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4421778A (en) * 1982-11-04 1983-12-20 Rich Products Corporation Freezer stable whipped ice cream and milk shake food products
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
ATE196733T1 (de) 2000-10-15
CA2126441A1 (en) 1993-07-08
CN1074228A (zh) 1993-07-14
ZA929161B (en) 1993-05-25
ES2150438T3 (es) 2000-12-01
EP0619731A4 (de) 1995-05-03
DE69231499T2 (de) 2001-05-03
US5725886A (en) 1998-03-10
FI943121A7 (fi) 1994-06-29
EP0619731B1 (de) 2000-10-04
FI943121A0 (fi) 1994-06-29
DE69231499D1 (de) 2000-11-09
NO942457L (no) 1994-06-29
JPH06511255A (ja) 1994-12-15
JP2628230B2 (ja) 1997-07-09
CA2126441C (en) 1999-12-21
IL104087A0 (en) 1993-05-13
FI943121L (fi) 1994-06-29
NO942457D0 (no) 1994-06-29
AU663146B2 (en) 1995-09-28
AU3179393A (en) 1993-07-28
EP0619731A1 (de) 1994-10-19
BR9206996A (pt) 1995-12-05
MX9207438A (es) 1993-06-01
WO1993012768A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
EP0619731B1 (de) Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
US6264989B1 (en) Spherical single-substance particles, medicines and foodstuffs containing the particles, and method of production thereof
EP0608850B1 (de) Verfahren zur Herstellung von Mikrogranulaten, die nach Umhüllung zur Suspendierung in flüssigen Pharmazeutika geeignet sind
EP0970705B1 (de) Agglomerate oder sphärische teilchen aus polyvalenten metall-alginaten, an die agglomerate gebundene zusammensetzungen für die kontrollierte freisetzung, die schwerlösliche medikamente enthalten, und verfahren für ihre herstellung
AU764280B2 (en) Process for the preparation of pellets with a content of up to 90 wt. per cent of a pharmaceutical active ingredient
CN1146773A (zh) 多孔颗粒聚集体及其制备方法
DE69625813T2 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
JP3349535B2 (ja) 球形顆粒の製造方法
Torre et al. Formulation and characterization of calcium alginate beads containing ampicillin
JPH0284401A (ja) 多孔性微小セルロース粒子
DE602004006009T2 (de) Pellets mit venlafaxin-hydrochlorid
KR20010112440A (ko) 비수용성 비정질 또는 부분비정질 서방성 매트릭스의 제조방법
CA2556514C (en) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
JPH10139659A (ja) 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
IE904666A1 (en) Spray drying process for making pharmaceutical powder¹compositions directly compressible into tablets
JP3219787B2 (ja) 球形粒子の製造方法
Zhang et al. Effect of spheronization technique on drug release from uncoated beads
JP3910939B2 (ja) 単一物質球形粒、それらを用いた食品、医薬及びそれらの製法
EP3892263A1 (de) Orale darreichungsform
JPS63222112A (ja) 徐放性顆粒
JPH05163162A (ja) 球形顆粒の製造方法
JP2007008872A (ja) 造粒粒子の製造方法およびその造粒粒子、並びに固形製剤
JPH08217801A (ja) 球形顆粒用水膨潤性球状核および球形顆粒並びにそれらの製造方法
JP2011207851A (ja) 膨潤性の球状核
US20030206953A1 (en) Aggregates of spherical multivalent metal alginate microparticles and methods of making them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees